{"name":"Iacta Pharmaceuticals","slug":"iacta-pharmaceuticals","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxQa1EzVDFkU3FmY1VUajZ6ZXhnVnBNTjdURXNES3dsRVpYNDlRU1dweUg1Y3lIZ2ZueDhsTFo2anE2dHIyeHhFX1NDUU5pdUtBV3VFdl9vOUNCcU9NejhKZUJnY21jdy1ISFNrYWxYSlVWZl9kX1l1c2hVdUZfVlhaSUtWTDM4MHBzbTFiU3lBdFRDQkkz?oc=5","date":"2026-04-06","type":"trial","source":"openPR.com","summary":"Allergic Conjunctivitis Clinical Trials Landscape 2026: - openPR.com","headline":"Allergic Conjunctivitis Clinical Trials Landscape 2026:","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxOSV9oaDdkVU4yTmctbGQ1LWs1bDBwWEJkVnRTVWZDRkdLZUtCclpWRHYtS0FNQS1Jd2JJOEMxZ2NPNXJST1JzdmhhLWFFRVBiM1NyUWpLZkxIUmM5WWZEaUUzekdxaUlVbm9tYTBTNUVrb1d0R3hCaUY0R1dCV1lUbDR0WTJrYzBQakd1WUhVNzFIMThKcm5wcExBa2o4cXhTdG9XSVF2aUQyRFk?oc=5","date":"2021-12-21","type":"pipeline","source":"Fierce Pharma","summary":"Iacta bags rights to Tallc's pan-ocular drug delivery technology - Fierce Pharma","headline":"Iacta bags rights to Tallc's pan-ocular drug delivery technology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwJBVV95cUxObG9fNnFzOFBNRlBFbzBLdUtNOEh6Uzd1akZubExnUnQ1dkFwTnp5RDBmempjQkp4UGE3bGhJck5aTENVZUZ4QkxvQW44RGJnMVZEN3A4QTktOVoxeVNrSUhETkpnRVIxcElrZ3NhLU5nd1NpVlloVlNkVC1ENzhabnR2YlVxbWtQR2RqcWpOTWJKOXhmZTEwa19vNm9pd3FrdVZRS0JSYkJKNnQzX21fWG1PLV95UEN5TEJhQ3ZZZ1ExbGJLa1IzSWJaaTcwV280VmtyWHJ1UWlfclc1cEF3ajNiaGZnNjBpeU9qUVJMbnhzN2dRWkpXQTJnRWRZTmZEME9oSVktTVVaVmFabUUxYmRHVUl1STFBLU9fcFdHeGxoMUhxazdzZ2hxeG9OUlM4MUN6MnFEVFhydV9obzB3a25uQQ?oc=5","date":"2020-07-28","type":"pipeline","source":"prnewswire.com","summary":"New Licensing Agreement Accelerates the Development of IACTA Pharmaceuticals' Novel Dry Eye Disease and Allergic Conjunctivitis Treatments in China and Southeast Asia - prnewswire.com","headline":"New Licensing Agreement Accelerates the Development of IACTA Pharmaceuticals' Novel Dry Eye Disease and Allergic Conjunc","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}